Safety of Continuing Metformin in Diabetic Patients With Normal Kidney Function Receiving Contrast Media
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether metformin causes lactic acidosis in
diabetic patients with preserved kidney function, undergoing coronary angiography or
angioplasty with new contrast media.
In other words is it necessary to discontinue metformin before these procedures, even when
Iodixanol is used as contrast media, which is isosmolar agent and much more safer than
urografin which was the main agent in the previous studies that were the base of present
guidelines?